Literature DB >> 8849418

Role of protein phosphatase in the regulation of Na+-K+-ATPase by vasopressin in the cortical collecting duct.

M Blot-Chabaud1, N Coutry, M Laplace, J Bonvalet, N Farman.   

Abstract

In the cortical collecting duct (CCD), arginin vasopressin (AVP) has been shown to increase the number and activity of basolateral Na+-K+-ATPase by recruiting or activating a latent pool of pumps. However, the precise mechanism of this phenomenon is still unknown. The aim of this study was to investigate whether this AVP-induced increase in basolateral Na+-K+-ATPase could depend on a dephosphorylation process. To this purpose, the effect of protein serine/threonine phosphatase (PP) inhibitors was examined on both the specific 3H-ouabain binding (to evaluate the number of pumps in the basolateral membrane) and the ouabain-dependent 86Rb uptake (to evaluate pump functionality) in the presence or absence of AVP. In addition, the activity of two PP, PP1 and PP2A, was measured and the influence of AVP was examined on both enzymes. Experiments have been performed on mouse CCD isolated by microdissection. Results show that inhibition of PP2A prevents the AVP-induced increase in the number and activity of Na+-K+-ATPases, independent of an effect on the apical cell sodium entry. In addition, AVP rapidly increased the activity of PP2A without effect on PP1. These data suggest that PP2A is implied in the regulation of Na+-K+-ATPase activity by AVP in the CCD and that the AVP-dependent increase in the number of Na+-K+-ATPases is mediated by a PP2A-dependent dephosphorylation process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849418     DOI: 10.1007/s002329900126

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  8 in total

1.  Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.

Authors:  Boubacar Benziane; Marie Björnholm; Sergej Pirkmajer; Reginald L Austin; Olga Kotova; Benoit Viollet; Juleen R Zierath; Alexander V Chibalin
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

2.  Regulation of human and pig renal Na(+),K (+)-ATPase activity by tyrosine phosphorylation of their alpha(1)-subunits.

Authors:  Waleed El-Beialy; Nadia Galal; Yoshiaki Deyama; Yoshitaka Yoshimura; Kuniaki Suzuki; Kanchu Tei; Yasunori Totsuka
Journal:  J Membr Biol       Date:  2010-02-04       Impact factor: 1.843

Review 3.  Avian Toxins and Poisoning Mechanisms.

Authors:  Kara A Yeung; Peter R Chai; Brendan L Russell; Timothy B Erickson
Journal:  J Med Toxicol       Date:  2022-04-26

4.  Vasotocin has the potential to inhibit basolateral Na(+)/K (+)-pump current across isolated skin of tree frog in vitro, via its V(2)-type receptor/cAMP pathway.

Authors:  Makoto Takada; Kayo Fujimaki; Shigeru Hokari
Journal:  J Comp Physiol B       Date:  2008-06-07       Impact factor: 2.200

5.  Norcantharidin inhibits renal interstitial fibrosis by downregulating PP2Ac expression.

Authors:  Tao Hou; Zheng Xiao; Ying Li; Yan-Hua You; Hua Li; Yu-Ping Liu; Yi-Yun Xi; Jun Li; Shao-Bin Duan; Hong Liu; Lin Sun; You-Ming Peng; Fu-You Liu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

6.  Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin.

Authors:  Cécilia Chassin; Mathias W Hornef; Marcelle Bens; Michael Lotz; Jean-Michel Goujon; Sophie Vimont; Guillaume Arlet; Alexandre Hertig; Eric Rondeau; Alain Vandewalle
Journal:  J Exp Med       Date:  2007-10-29       Impact factor: 14.307

Review 7.  The role of cullin 5-containing ubiquitin ligases.

Authors:  Fumihiko Okumura; Akiko Joo-Okumura; Kunio Nakatsukasa; Takumi Kamura
Journal:  Cell Div       Date:  2016-03-09       Impact factor: 5.130

8.  Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.

Authors:  Elena Arystarkhova; Richard Bouley; Yi Bessie Liu; Kathleen J Sweadner
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.